ASM Clinical Microbiology Issues Update Invite - BCC

Appendix L1

ASM Clinical Microbiology Issues Update
Month, Year
Volume XX, Number
To read this newsletter on-line, go to:

PSAB ACTIVITIES


ASM Applauds FY 2015 Budget’s Increased Funding to Fight Antibiotic
Resistance



ASM Endorses American Cures Act of 2015



ASM and PASCV Issue Joint Statement on FDA’s LDT



ASM Participates in CDC Telebriefing on the Ebola Outbreak in West Africa



ASM Attends December CCCLW Meeting



ASM Signs Implementation Letter on Combatting Antimicrobial Resistance



ASM attends FDA Anti-Infective Drugs Advisory Committee Meeting



ASM Meets with Officials from WRAIR



Minority Microbiology Mentor Newsletter

ASM NEWS, JOURNAL ARTICLES AND UPDATES



Blood Culture Contamination Laboratory Practice Survey



Laboratory Practice Survey



December Clinical Microbiology Portal Hot Topic



Clinical Microbiology Portal Q & A



ASM Conferences



ASM Journal Articles of Interest



ASM Press



Articles of Interest

FEDERAL AGENCY UPDATES



FDA Grants First CLIA Waiver for Nucleic Acid-Based Flu Diagnostic Test



Emergency Use Authorizations of In Vitro Diagnostic Devices for Detection of
Ebola Zaire Virus



Optimizing FDA’s Regulatory Oversight of Next Generation Sequencing
Diagnostic Tests



FDA Approves a Second Vaccine to Prevent serogroup B Meningococcal
Disease



FDA Approves New Antibacterial Drug Zerbaxa



FDA Approves Pathogen Reduction System to Treat Platelets



FDA Approves First Pathogen Reduction System to Treat Plasma



FDA Grants CLIA Waiver Expanding the Availability of Rapid Screening Test
for Syphilis



MMWR Articles of Interest

OTHER INFORMATION AND UPDATES



Articles of Interest

ASM NEWS, JOURNAL ARTICLES AND UPDATES

Blood Culture Contamination Laboratory Practice Survey
The American Society for Microbiology (ASM) and the Centers for Disease Control
and Prevention (CDC) are conducting a survey to learn about laboratories’ practices
and policies for reducing blood culture contamination with the goal of improving
practice and patient care. The baseline and post-surveys will each take approximately
35 minutes to complete; participation is voluntary. The results from the survey will be
compiled and shared in aggregate as a learning tool, presented at professional
conferences and potentially published in a professional journal in the field of laboratory
science. All information collected in these surveys will be kept in a secure manner;
your IP address will NOT be retained.
If your laboratory has not yet participated in the baseline survey, please visit
https://www.surveymonkey.com/s/3Y9Z38P and complete it by (date to be determined
by OMB approval). If your laboratory has not yet participated in the post-survey, which
was distributed six months after the baseline survey, please visit
https://www.surveymonkey.com/s/6TNXKMF and complete it by (date to be
determined by OMB approval). Your feedback is critical to guiding ASM and CDC in
their efforts to improve practice and patient care. Contact clinmicro@asmusa.org with
questions or concerns.

American Society For Microbiology © 2015